APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Biomedical

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Artificial Intelligence in Biomedical Industry Growth and Trends Forecast to 2032

3 July 2026124 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Biomedical Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Biomedical Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Biomedical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Biomedical Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Biomedical Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Artificial Intelligence in Biomedical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Artificial Intelligence in Biomedical market include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Artificial Intelligence in Biomedical market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artificial Intelligence in Biomedical market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Intelligence in Biomedical market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Intelligence in Biomedical.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Artificial Intelligence in Biomedical market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artificial Intelligence in Biomedical Market by Company

AstraZeneca

Thales Group

IBM Corp.

ForeSee Medical

Atomwise

Cloud Pharmaceuticals

GNS Healthcare

Microsoft Corporation

Novartis AG

NVIDIA Corporation

Pfizer

Recursion Pharmaceuticals

XtalPi Inc

Aidoc

AliveCor

GE Healthcare

Imagen Technologies

Vuno Inc.

IDx Technologies Inc.

Siemens Healthcare GmbH

Neural Analytics

Artificial Intelligence in Biomedical Segment by Type

Hardware

Software

Artificial Intelligence in Biomedical Segment by Application

Diagnosing Diseases

Developing Drugs

Personalized Treatment

Other

Artificial Intelligence in Biomedical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Biomedical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Biomedical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Biomedical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Artificial Intelligence in Biomedical companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Biomedical Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Artificial Intelligence in Biomedical Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Artificial Intelligence in Biomedical Market Share by Region (2021-2026) Table 4. Global Artificial Intelligence in Biomedical Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Artificial Intelligence in Biomedical Market Share by Region (2027-2032) Table 6. Global Artificial Intelligence in Biomedical Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Artificial Intelligence in Biomedical Market Size Share by Type (2021-2026) Table 9. Global Artificial Intelligence in Biomedical Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Artificial Intelligence in Biomedical Market Size Share Forecasted by Type (2027-2032) Table 11. North America Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Artificial Intelligence in Biomedical Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Artificial Intelligence in Biomedical Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Artificial Intelligence in Biomedical Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Artificial Intelligence in Biomedical Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Artificial Intelligence in Biomedical Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Artificial Intelligence in Biomedical Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Artificial Intelligence in Biomedical Market Size Share by Application (2021-2026) Table 24. Global Artificial Intelligence in Biomedical Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Artificial Intelligence in Biomedical Market Size Share Forecasted by Application (2027-2032) Table 26. North America Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Artificial Intelligence in Biomedical Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Artificial Intelligence in Biomedical Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Artificial Intelligence in Biomedical Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Artificial Intelligence in Biomedical Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Artificial Intelligence in Biomedical Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Artificial Intelligence in Biomedical Industry Trends Table 37. Artificial Intelligence in Biomedical Industry Drivers Table 38. Artificial Intelligence in Biomedical Industry Opportunities and Challenges Table 39. Artificial Intelligence in Biomedical Industry Restraints Table 40. Global Artificial Intelligence in Biomedical Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Artificial Intelligence in Biomedical Revenue Market Share by Company (2021-2026) Table 42. Global Artificial Intelligence in Biomedical Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Artificial Intelligence in Biomedical Key Company Headquarters & Area Served Table 44. Global Artificial Intelligence in Biomedical Company, Product Type & Application Table 45. Global Artificial Intelligence in Biomedical Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Artificial Intelligence in Biomedical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AstraZeneca Artificial Intelligence in Biomedical Product Portfolio Table 52. AstraZeneca Recent Development Table 53. Thales Group Company Information Table 54. Thales Group Business Overview Table 55. Thales Group Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Thales Group Artificial Intelligence in Biomedical Product Portfolio Table 57. Thales Group Recent Development Table 58. IBM Corp. Company Information Table 59. IBM Corp. Business Overview Table 60. IBM Corp. Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. IBM Corp. Artificial Intelligence in Biomedical Product Portfolio Table 62. IBM Corp. Recent Development Table 63. ForeSee Medical Company Information Table 64. ForeSee Medical Business Overview Table 65. ForeSee Medical Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio Table 67. ForeSee Medical Recent Development Table 68. Atomwise Company Information Table 69. Atomwise Business Overview Table 70. Atomwise Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Atomwise Artificial Intelligence in Biomedical Product Portfolio Table 72. Atomwise Recent Development Table 73. Cloud Pharmaceuticals Company Information Table 74. Cloud Pharmaceuticals Business Overview Table 75. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 77. Cloud Pharmaceuticals Recent Development Table 78. GNS Healthcare Company Information Table 79. GNS Healthcare Business Overview Table 80. GNS Healthcare Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 82. GNS Healthcare Recent Development Table 83. Microsoft Corporation Company Information Table 84. Microsoft Corporation Business Overview Table 85. Microsoft Corporation Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio Table 87. Microsoft Corporation Recent Development Table 88. Novartis AG Company Information Table 89. Novartis AG Business Overview Table 90. Novartis AG Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novartis AG Artificial Intelligence in Biomedical Product Portfolio Table 92. Novartis AG Recent Development Table 93. NVIDIA Corporation Company Information Table 94. NVIDIA Corporation Business Overview Table 95. NVIDIA Corporation Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio Table 97. NVIDIA Corporation Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pfizer Artificial Intelligence in Biomedical Product Portfolio Table 102. Pfizer Recent Development Table 103. Recursion Pharmaceuticals Company Information Table 104. Recursion Pharmaceuticals Business Overview Table 105. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 107. Recursion Pharmaceuticals Recent Development Table 108. XtalPi Inc Company Information Table 109. XtalPi Inc Business Overview Table 110. XtalPi Inc Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio Table 112. XtalPi Inc Recent Development Table 113. Aidoc Company Information Table 114. Aidoc Business Overview Table 115. Aidoc Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Aidoc Artificial Intelligence in Biomedical Product Portfolio Table 117. Aidoc Recent Development Table 118. AliveCor Company Information Table 119. AliveCor Business Overview Table 120. AliveCor Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AliveCor Artificial Intelligence in Biomedical Product Portfolio Table 122. AliveCor Recent Development Table 123. GE Healthcare Company Information Table 124. GE Healthcare Business Overview Table 125. GE Healthcare Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. GE Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 127. GE Healthcare Recent Development Table 128. Imagen Technologies Company Information Table 129. Imagen Technologies Business Overview Table 130. Imagen Technologies Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio Table 132. Imagen Technologies Recent Development Table 133. Vuno Inc. Company Information Table 134. Vuno Inc. Business Overview Table 135. Vuno Inc. Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio Table 137. Vuno Inc. Recent Development Table 138. IDx Technologies Inc. Company Information Table 139. IDx Technologies Inc. Business Overview Table 140. IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio Table 142. IDx Technologies Inc. Recent Development Table 143. Siemens Healthcare GmbH Company Information Table 144. Siemens Healthcare GmbH Business Overview Table 145. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio Table 147. Siemens Healthcare GmbH Recent Development Table 148. Neural Analytics Company Information Table 149. Neural Analytics Business Overview Table 150. Neural Analytics Artificial Intelligence in Biomedical Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Neural Analytics Artificial Intelligence in Biomedical Product Portfolio Table 152. Neural Analytics Recent Development Table 153. North America Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Artificial Intelligence in Biomedical Market Share by Country (2021-2026) Table 156. North America Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Artificial Intelligence in Biomedical Market Share Forecast by Country (2027-2032) Table 158. Europe Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Artificial Intelligence in Biomedical Market Share by Country (2021-2026) Table 161. Europe Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Artificial Intelligence in Biomedical Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Country (2021-2026) Table 166. Asia-Pacific Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Artificial Intelligence in Biomedical Market Share Forecast by Country (2027-2032) Table 168. Latin America Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Artificial Intelligence in Biomedical Market Share by Country (2021-2026) Table 171. Latin America Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Artificial Intelligence in Biomedical Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country (2021-2026) Table 176. Middle East & Africa Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Artificial Intelligence in Biomedical Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Artificial Intelligence in Biomedical Product Image Figure 3. Global Artificial Intelligence in Biomedical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 5. Global Artificial Intelligence in Biomedical Market Share by Region: 2025 VS 2032 Figure 6. Global Artificial Intelligence in Biomedical Market Share by Region (2021-2032) Figure 7. North America Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Hardware Image Figure 13. Global Hardware Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Software Image Figure 15. Global Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Artificial Intelligence in Biomedical Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Artificial Intelligence in Biomedical Market Share by Type 2025 VS 2032 Figure 18. North America Artificial Intelligence in Biomedical Market Size Share by Type (2021-2032) Figure 19. Europe Artificial Intelligence in Biomedical Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Artificial Intelligence in Biomedical Market Size Share by Type (2021-2032) Figure 21. Latin America Artificial Intelligence in Biomedical Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Artificial Intelligence in Biomedical Market Size Share by Type (2021-2032) Figure 23. Diagnosing Diseases Image Figure 24. Global Diagnosing Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Developing Drugs Image Figure 26. Global Developing Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Personalized Treatment Image Figure 28. Global Personalized Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Artificial Intelligence in Biomedical Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Artificial Intelligence in Biomedical Market Share by Application 2025 VS 2032 Figure 33. North America Artificial Intelligence in Biomedical Market Size Share by Application (2021-2032) Figure 34. Europe Artificial Intelligence in Biomedical Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Artificial Intelligence in Biomedical Market Size Share by Application (2021-2032) Figure 36. Latin America Artificial Intelligence in Biomedical Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Artificial Intelligence in Biomedical Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Artificial Intelligence in Biomedical Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Artificial Intelligence in Biomedical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Artificial Intelligence in Biomedical Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 43. Europe Artificial Intelligence in Biomedical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Artificial Intelligence in Biomedical Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 46. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 49. Latin America Artificial Intelligence in Biomedical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Artificial Intelligence in Biomedical Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 52. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Diagnosing Diseases
  • Developing Drugs
  • Personalized Treatment
  • Other
Companies covered
  • AstraZeneca
  • Thales Group
  • IBM Corp.
  • ForeSee Medical
  • Atomwise
  • Cloud Pharmaceuticals
  • GNS Healthcare
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer
  • Recursion Pharmaceuticals
  • XtalPi Inc
  • Aidoc
  • AliveCor
  • GE Healthcare
  • Imagen Technologies
  • Vuno Inc.
  • IDx Technologies Inc.
  • Siemens Healthcare GmbH
  • Neural Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Artificial Intelligence in Biomedical Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Artificial Intelligence in Biomedical Market Size by Region (2021-2032)
  5. 1.4.1 Global Artificial Intelligence in Biomedical Market Size by Region (2021-2026)
  6. 1.4.2 Global Artificial Intelligence in Biomedical Market Size by Region (2027-2032)
  7. 1.5 Key Regions Artificial Intelligence in Biomedical Market Size (2021-2032)
  8. 1.5.1 North America Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Artificial Intelligence in Biomedical Market Size Growth Rate (2021-2032)
2 Artificial Intelligence in Biomedical Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Hardware
  3. 2.1.2 Software
  4. 2.2 Global Artificial Intelligence in Biomedical Market Size by Type
  5. 2.2.1 Global Artificial Intelligence in Biomedical Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Artificial Intelligence in Biomedical Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Artificial Intelligence in Biomedical Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Artificial Intelligence in Biomedical Market Size by Regions
  9. 2.3.1 North America Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Artificial Intelligence in Biomedical Market Size Breakdown by Type (2021-2026)
3 Artificial Intelligence in Biomedical Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Diagnosing Diseases
  3. 3.1.2 Developing Drugs
  4. 3.1.3 Personalized Treatment
  5. 3.1.4 Other
  6. 3.2 Global Artificial Intelligence in Biomedical Market Size by Application
  7. 3.2.1 Global Artificial Intelligence in Biomedical Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Artificial Intelligence in Biomedical Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Artificial Intelligence in Biomedical Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Artificial Intelligence in Biomedical Market Size by Regions
  11. 3.3.1 North America Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Artificial Intelligence in Biomedical Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Artificial Intelligence in Biomedical Industry Trends
  2. 4.2 Artificial Intelligence in Biomedical Industry Drivers
  3. 4.3 Artificial Intelligence in Biomedical Industry Opportunities and Challenges
  4. 4.4 Artificial Intelligence in Biomedical Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Artificial Intelligence in Biomedical Revenue (2021-2026)
  2. 5.2 Global Artificial Intelligence in Biomedical Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Artificial Intelligence in Biomedical Key Company Headquarters & Area Served
  4. 5.4 Global Artificial Intelligence in Biomedical Company, Product Type & Application
  5. 5.5 Global Artificial Intelligence in Biomedical Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Artificial Intelligence in Biomedical Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Artificial Intelligence in Biomedical Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Artificial Intelligence in Biomedical Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Artificial Intelligence in Biomedical Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Thales Group
  8. 6.2.1 Thales Group Company Information
  9. 6.2.2 Thales Group Business Overview
  10. 6.2.3 Thales Group Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Thales Group Artificial Intelligence in Biomedical Product Portfolio
  12. 6.2.5 Thales Group Recent Developments
  13. 6.3 IBM Corp.
  14. 6.3.1 IBM Corp. Company Information
  15. 6.3.2 IBM Corp. Business Overview
  16. 6.3.3 IBM Corp. Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 IBM Corp. Artificial Intelligence in Biomedical Product Portfolio
  18. 6.3.5 IBM Corp. Recent Developments
  19. 6.4 ForeSee Medical
  20. 6.4.1 ForeSee Medical Company Information
  21. 6.4.2 ForeSee Medical Business Overview
  22. 6.4.3 ForeSee Medical Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio
  24. 6.4.5 ForeSee Medical Recent Developments
  25. 6.5 Atomwise
  26. 6.5.1 Atomwise Company Information
  27. 6.5.2 Atomwise Business Overview
  28. 6.5.3 Atomwise Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Atomwise Artificial Intelligence in Biomedical Product Portfolio
  30. 6.5.5 Atomwise Recent Developments
  31. 6.6 Cloud Pharmaceuticals
  32. 6.6.1 Cloud Pharmaceuticals Company Information
  33. 6.6.2 Cloud Pharmaceuticals Business Overview
  34. 6.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  36. 6.6.5 Cloud Pharmaceuticals Recent Developments
  37. 6.7 GNS Healthcare
  38. 6.7.1 GNS Healthcare Company Information
  39. 6.7.2 GNS Healthcare Business Overview
  40. 6.7.3 GNS Healthcare Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio
  42. 6.7.5 GNS Healthcare Recent Developments
  43. 6.8 Microsoft Corporation
  44. 6.8.1 Microsoft Corporation Company Information
  45. 6.8.2 Microsoft Corporation Business Overview
  46. 6.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio
  48. 6.8.5 Microsoft Corporation Recent Developments
  49. 6.9 Novartis AG
  50. 6.9.1 Novartis AG Company Information
  51. 6.9.2 Novartis AG Business Overview
  52. 6.9.3 Novartis AG Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novartis AG Artificial Intelligence in Biomedical Product Portfolio
  54. 6.9.5 Novartis AG Recent Developments
  55. 6.10 NVIDIA Corporation
  56. 6.10.1 NVIDIA Corporation Company Information
  57. 6.10.2 NVIDIA Corporation Business Overview
  58. 6.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio
  60. 6.10.5 NVIDIA Corporation Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Artificial Intelligence in Biomedical Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Recursion Pharmaceuticals
  68. 6.12.1 Recursion Pharmaceuticals Company Information
  69. 6.12.2 Recursion Pharmaceuticals Business Overview
  70. 6.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  72. 6.12.5 Recursion Pharmaceuticals Recent Developments
  73. 6.13 XtalPi Inc
  74. 6.13.1 XtalPi Inc Company Information
  75. 6.13.2 XtalPi Inc Business Overview
  76. 6.13.3 XtalPi Inc Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio
  78. 6.13.5 XtalPi Inc Recent Developments
  79. 6.14 Aidoc
  80. 6.14.1 Aidoc Company Information
  81. 6.14.2 Aidoc Business Overview
  82. 6.14.3 Aidoc Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Aidoc Artificial Intelligence in Biomedical Product Portfolio
  84. 6.14.5 Aidoc Recent Developments
  85. 6.15 AliveCor
  86. 6.15.1 AliveCor Company Information
  87. 6.15.2 AliveCor Business Overview
  88. 6.15.3 AliveCor Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AliveCor Artificial Intelligence in Biomedical Product Portfolio
  90. 6.15.5 AliveCor Recent Developments
  91. 6.16 GE Healthcare
  92. 6.16.1 GE Healthcare Company Information
  93. 6.16.2 GE Healthcare Business Overview
  94. 6.16.3 GE Healthcare Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 GE Healthcare Artificial Intelligence in Biomedical Product Portfolio
  96. 6.16.5 GE Healthcare Recent Developments
  97. 6.17 Imagen Technologies
  98. 6.17.1 Imagen Technologies Company Information
  99. 6.17.2 Imagen Technologies Business Overview
  100. 6.17.3 Imagen Technologies Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio
  102. 6.17.5 Imagen Technologies Recent Developments
  103. 6.18 Vuno Inc.
  104. 6.18.1 Vuno Inc. Company Information
  105. 6.18.2 Vuno Inc. Business Overview
  106. 6.18.3 Vuno Inc. Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio
  108. 6.18.5 Vuno Inc. Recent Developments
  109. 6.19 IDx Technologies Inc.
  110. 6.19.1 IDx Technologies Inc. Company Information
  111. 6.19.2 IDx Technologies Inc. Business Overview
  112. 6.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio
  114. 6.19.5 IDx Technologies Inc. Recent Developments
  115. 6.20 Siemens Healthcare GmbH
  116. 6.20.1 Siemens Healthcare GmbH Company Information
  117. 6.20.2 Siemens Healthcare GmbH Business Overview
  118. 6.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio
  120. 6.20.5 Siemens Healthcare GmbH Recent Developments
  121. 6.21 Neural Analytics
  122. 6.21.1 Neural Analytics Company Information
  123. 6.21.2 Neural Analytics Business Overview
  124. 6.21.3 Neural Analytics Artificial Intelligence in Biomedical Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Neural Analytics Artificial Intelligence in Biomedical Product Portfolio
  126. 6.21.5 Neural Analytics Recent Developments
7 North America
  1. 7.1 North America Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  3. 7.3 North America Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  3. 8.3 Europe Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  3. 10.3 South America Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Artificial Intelligence in Biomedical Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst